C19orf48P and lung adenocarcinoma: It showed that the elevated expression of c19orf48 contributed to the short overall survival time in several types of cancers including breast cancer, cervical squamous cell carcinoma, kidney renal clear cell carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma and sarcoma (Figure 3).